Rethinking the vulnerability of minority populations in research

American Journal of Public Health

Volumn 103, Issue 12, 2013, Pages 2141-2146

  Rogers, Wendy ^a   Lange, Margaret Meek ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ETHICS; HUMAN; HUMAN EXPERIMENT; MEDICAL RESEARCH; MINORITY GROUP; PRACTICE GUIDELINE; UNITED STATES; VULNERABLE POPULATION;

BIOMEDICAL RESEARCH; GUIDELINES AS TOPIC; HUMAN EXPERIMENTATION; HUMANS; MINORITY GROUPS; UNITED STATES; VULNERABLE POPULATIONS;

EID: 84887286429     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2012.301200     Document Type: Article

References (41)

1. World Medical Association. 2008. Declaration of Helsinki. Available at: Http://www.wma.net/en/30publications/10policies/b3/Accessed 15 Oct 2012.
2. The National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington, D.C.: Department of Health, Education, and Welfare; 1979.
3. Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. 2002. Available at: Http://www.cioms.ch/publications/layout-guide2002. pdf Accessed October 15, 2012.
4. Kipnis K. Seven vulnerabilities in the pediatric research subject. Theor Med Bioeth. 2003;24(2):107-120.
5. Rogers W, Ballantyne AJ. Special populations: Vulnerability and protection. RECIIS Electron J Commun Inf Innovation Health. 2008;2(suppl 1):S30-S40.
6. Office of Human Research Protection (OHRP). Code of Federal Regulations for the Protection of Human Subjects. Available at: Http://www.hhs.gov/ohrp/ policy/ohrpregulations.pdf Accessed December 17, 2012.
7. Hurst SA. Vulnerability in research and health care; describing the elephant in the room? Bioethics. 2008;22:191-202.
8. Luna F. Elucidating the concept of vulnerability: Layers not labels. Int J Fem Approaches Bioeth. 2009;2:121-139.
9. Lyerly AD, Little MO, Faden R. The second wave: Toward responsible inclusion of pregnant women in research. Int J Fem Approaches Bioeth. 2008;1(2):5-22.
10. Beecher HK. Ethics and clinical research. N Engl J Med. 1966;274: 1354-1360.
11. Nickel PJ. Vulnerable populations in research: The case of the seriously ill. Theor Med Bioeth. 2006;27:245-264.
12. Bielby P. Competence and Vulnerability in Biomedical Research. New York: Springer; 2008.
13. Levine C, Faden R, Grady C, et al. The limitations of "vulnerability" as a protection for human research participants. Am J Bioeth. 2004;4(3):44-49.
14. Macklin R. Bioethics, vulnerability and protection. Bioethics. 2003;17: 472-486.
15. Rogers WA. Evidence-based medicine and justice: A framework for looking at the impact of EBM on vulnerable or disadvantaged groups. J Med Ethics. 2004;30:141-145.
16. Chiu CT, Katz RV. Identifying the "vulnerables" in biomedical research: The vox populis from the Tuskegee Legacy Project. J Public Health Dent. 2011;71(3): 220-228.
17. Ranganathan M, Bhopal R. Exclusion and inclusion of nonwhite ethnic minority groups in 72 North American and European cardiovascular cohort studies. PLoS Med. 2006;3(3):e44.
18. Bartlett C, Doyal L, Ebrahim S, et al. The causes and effects of sociodemographic exclusions from clinical trials. Health Technol Assess. 2005;9(38).
19. Nazroo JY. The structuring of ethnic inequalities in health: economic position, racial discrimination, and racism. Am J Public Health. 2003;93:277-284.
20. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med. 2006;3(2):e19.
21. Hodge FS, Weinmann S, Roubideaux Y. Recruitment of American Indians and Alaska Natives into clinical trials. Ann Epidemiol. 2000;10(8, suppl):S41-S48.
22. Jones JH. The Tuskegee Syphilis Experiment. In: Emanuel EJ, Grady C, Crouch RA, Lie RK, Miller FG, Wendler D, eds. The Oxford Textbook of Clinical Research Ethics. Oxford, UK: Oxford University Press; 2008:86-96.
23. Hodge FS. No meaningful apology for American Indian unethical research abuses. Ethics Behav. 2012;22(6):431-444.
24. Samsudeen BS, Douglas A, Bhopal RS. Challenges in recruiting South Asians into prevention trials: Health professional and community recruiters' perceptions on the PODOSA trial. Public Health. 2011;125(4):201-209.
25. Fisher JA, Kalbaugh CA. Challenging assumptions about minority participation in US clinical research. Am J Public Health. 2011;101(12):2217- 2222.
26. Elliott C, Abadie R. Exploiting a research underclass in phase 1 clinical trials. N Engl J Med. 2008;358(22): 2316-2317.
27. Ballantyne A. Benefits to research subjects in international trials: do they reduce exploitation or increase undue inducement? Dev World Bioeth. 2008; 8(3):178-191.
28. Grady C. Money for research participation: does it jeopardize informed consent? Am J Bioeth. 2001;1(2):40-44.
29. Resnik DB. Research participation and financial inducements. Am J Bioeth. 2001;1(2):54-56.
30. Savulescu J. The Fiction of 'Undue Inducement': Why researchers should be allowed to pay participants any amount of money for any reasonable research project. Am J Bioeth. 2001;1(2):1g-3g.
31. Australian Government: National Health and Medical Research Council. 2003. Guidelines for Ethical Conduct in Aboriginal and Torres Strait Islander Health Research. Available at: Http://www.nhmrc.gov.au/guidelines/publications/ e52. Accessed December 16, 2012.
32. Rogers W, Mackenzie C, Dodds S. Why bioethics needs a concept of vulnerability. Int J Fem Approaches Bioeth. 2012;5(2):11-38.
33. Lo B, Garan N. Research with Ethnic and Minority Populations. In: Emanuel EJ, Grady C, Crouch RA, Lie RK, Miller FG, Wendler D, eds. The Oxford Textbook of Clinical Research Ethics. Oxford: Oxford University Press; 2008:423-430.
34. Warne D, Kaur J, Perdue D. Indian/Alaska Native cancer policy: systemic approaches to reducing cancer disparities. J Cancer Educ. 2012;27(suppl 1): S18-S23.
35. Motulsky AG. Frequency of sickling disorders in U.S. blacks. N Engl J Med. 1973;288:31-33.
36. Williams DR, Mohammed SA, Leavell J, Collins C. Race, socioeconomic status, and health: Complexities, ongoing challenges, and research opportunities. Ann N Y Acad Sci. 2010;1186:69-101.
37. Lantz PM, Lichtenstein RL, Pollack HA. Health policy approaches to population health: The limits of medicalization. Health Aff (Millwood). 2007;26(5): 1253-1257.
38. Wallerstein N, Duran B. Communitybased participatory research contributions to intervention research: The intersection of science and practice to improve health equity. Am J Public Health. 2010;100(suppl 1): S40-S46.
39. Rothman RL, DeWalt DA, Malone R, et al. Influence of patient literacy on the effectiveness of a primary care-based diabetes disease management program. JAMA. 2004;292(14):1711-1716.
40. Kilbourne AM, Switzer G, Hyman K, Crowley-Matoka M, Fine MJ. Advancing health disparities research within the health care system: A conceptual framework. Am J Public Health. 2006;96(12): 2113-2121.
41. Shamoo AE, Resnik DB. Strategies to minimize risks and exploitation in phase one trials on healthy subjects. Am J Bioeth. 2006;6(3):W1-13.